gbm
Showing 1 - 25 of 52
Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))
Recruiting
- Glioblastoma
- GBM
- XS005 Cell Injection
- Temozolomide(TMZ)
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023
GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)
Recruiting
- GBM
- Postoperative radiotherapy for SVZ
-
Nanjing, Jiangsu, ChinaLining Guo
Oct 14, 2023
Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))
Not yet recruiting
- Recurrent Glioblastoma
- +2 more
- 5-ALA and Low-Intensity Focused Ultrasound (SDT)
-
Charlottesville, VirginiaUniversity of Virginia
Sep 10, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine
Recruiting
- Glioblastoma, IDH-wildtype
- +4 more
- Eflornithine (Dose Level 1)
- +3 more
-
Cleveland, OhioThe Cleveland Clinic
May 19, 2023
GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)
Recruiting
- GBM
- +2 more
- Whole Brain Spectroscopy Imaging Array Mapping Layout
-
Philadelphia, Pennsylvania
- +1 more
Jan 19, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)
Active, not recruiting
- Advanced Solid Tumors
- +15 more
- (no location specified)
Sep 16, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,
Recruiting
- Glioblastoma
- +3 more
- Radiation: Intra-operative Radiation Therapy - IORT
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Health Center
Jul 14, 2022
MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))
Completed
- MGMT-unmethylated Glioblastoma (GBM)
- GBM
- Nivolumab
- +2 more
-
New York, New YorkNew York University School of Medicine
Jun 30, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral
Recruiting
- Glioblastoma
- +6 more
- Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
- Temozolomide and Radiation Alone
-
New York, New YorkLenox Hill Brain Tumor Center
May 5, 2022
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))
Active, not recruiting
- Glioma
- +4 more
- VAL-083 (Dianhydrogalactitol)
-
Guangzhou, ChinaSun Yat-Sen University Cancer Center
Mar 23, 2022
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)
Active, not recruiting
- Glioma
- +4 more
- VAL-083, Dianhydrogalactitol
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
GBM Trial in Taichung, Taoyuan (autologous dendritic cells)
Recruiting
- GBM
- autologous dendritic cells
-
Taichung, Non-US, Taiwan
- +2 more
Mar 21, 2022
GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)
Active, not recruiting
- GBM
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Jan 23, 2022